Equities Trend Analysis: CVS Health Corporation (CVS), Occidental Petroleum Corporation (OXY), Philip Morris International Inc. (PM)

CVS Health Corporation (CVS) grew with the stock adding 0.05% or $0.04 to close at $79.45 on light trading volume of 4.96M compared its three months average trading volume of 7.75M. The Woonsocket Rhode Island 02895 based company operating under the Health Care Plans industry has been trending down for the last 52 weeks, with the shares price now -16.39% down for the period and up by 1.29% so far this year. With price target of $86.04 and a 15.34% rebound from 52-week low, CVS Health Corporation has plenty of upside potential, making it a hold with a view buy.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,709 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 38 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Occidental Petroleum Corporation (OXY) had a active trading with around 4.9M shares changing hands compared to its three month average trading volume of 4.72M. The stock traded between $66.36 and $67.38 before closing at the price of $66.44 with -1.15% change on the day. The Houston Texas 77046 based company is currently trading 4.34% above its 52 week low of $64.37 and -13.78% below its 52 week high of $78.48. Both the RSI indicator and target price of  and $76.3 respectively, lead us to believe that it could rise over the coming weeks.

Occidental Petroleum Corporation engages in the acquisition, exploration, and development of oil and gas properties in the United States and internationally. The company operates in three segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops, and produces oil and condensate, natural gas liquids (NGLs), and natural gas. The Chemical segment manufactures and markets basic chemicals, including chlorine, caustic soda, chlorinated organics, potassium chemicals, ethylene dichloride, chlorinated isocyanurates, sodium silicates, and calcium chloride; vinyls comprising vinyl chloride monomer and polyvinyl chloride; and other chemicals, such as resorcinol. The Midstream and Marketing segment gathers, processes, transports, stores, purchases, and markets oil, condensate, NGLs, natural gas, carbon dioxide, and power. This segment also trades around its assets consisting of transportation and storage capacity, as well as oil, NGLs, gas, and other commodities. Occidental Petroleum Corporation was founded in 1920 and is headquartered in Houston, Texas.

Philip Morris International Inc. (PM) saw its value increase by 0.06% as the stock gained $0.06 to finish the day at a closing price of $102.99. The stock was higher in trading and has fluctuated between $86.78-$104.2 per share for the past year. The shares, which traded within a range of $102.32 to $103.13 during the day, are up by 19.06% in the past three months and up by 4.95% over the past six months. It is currently trading 4.35% above its 20 day moving average and 9.83% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $103.81 a share over the next twelve months. The current relative strength index (RSI) reading is 80.93.The technical indicator do not lead us to believe the stock will see more gains any time soon.

Philip Morris International Inc., through its subsidiaries, manufactures and sells cigarettes, other tobacco products, and other nicotine-containing products. Its portfolio of brands comprises Marlboro, Merit, Parliament, Virginia S., L&M, Philip Morris, Bond Street, Chesterfield, Lark, Muratti, Next, and Red & White. The company also owns various cigarette brands, such as Dji Sam Soe, Sampoerna, and U Mild in Indonesia; Champion, Fortune, and Jackpot in the Philippines; Apollo-Soyuz and Optima in Russia; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It markets and sells its products in the European Union, Eastern Europe, the Middle East, Africa, Asia, Latin America, and Canada. Philip Morris International Inc. was incorporated in 1987 and is based in New York, New York.

 

Trader’s Round Up: Discovery Communications, Inc. (DISCA), CVS Health Corporation (CVS), S&P Global, Inc. (SPGI)

Discovery Communications, Inc. (DISCA) retreated with the stock falling -1.72% or $-0.5 to close at $28.53 on active trading volume of 7.14M compared its three months average trading volume of 2.75M. The Silver Spring Maryland 20910 based company operating under the CATV Systems industry has been trending up for the last 52 weeks, with the shares price now 11.62% up for the period and up by 4.09% so far this year. With price target of $27.8 and a 20.58% rebound from 52-week low, Discovery Communications, Inc. has plenty of upside potential, making it a hold with a view buy.

Discovery Communications, Inc. operates as a media company worldwide. It operates through U.S. Networks; International Networks; and Education and Other segments. The company owns and operates various television networks under the Discovery Channel, TLC, Animal Planet, Investigation Discovery, Science, Velocity, Discovery Family, American Heroes, Destination America, Discovery Life, Oprah Winfrey Network, Eurosport, DMAX, and Discovery Kids brands. Its content spans genres, including survival, exploration, sports, lifestyle, general entertainment, heroes, adventure, crime and investigation, health, and kids. The company also develops and sells curriculum-based education products and services comprising online suite of curriculum-based VOD tools, professional development services, and digital textbooks, as well as student assessments; and publishes hard copy curriculum-based content for K-12 schools. In addition, it operates production studios that develop content for television service providers, as well as Websites. The company provides content through various distribution platforms, including pay-TV, free-to-air and broadcast television, digital distribution arrangements, and content licensing agreements, as well as various platforms, such as brand-aligned Websites, Web-native networks, on-line streaming, mobile devices, video on demand (VOD), and broadband channels. As of December 31, 2015, it operated approximately 380 distribution feeds in 40 languages internationally. The company is headquartered in Silver Spring, Maryland.

CVS Health Corporation (CVS) dropped $-0.03 to close the day at a new closing price of $78.67, a -0.04% decrease in value from its previous closing price that moved the stock 14.21% above its 52 week low of $69.3. A total of 5.49M shares exchanged hands during the day compared with its three month average trading volume of 7.91M. The stock, which fluctuated between $78.06 and $78.95 during the day, currently situated -25.11% below its 52 week high. The stock is down by -3.46% in the past one month and up by 5.4% over the past three months. With a one year target estimate of $86.04 and RSI of 50.26, the stock still has upside potential, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,709 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 38 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

S&P Global, Inc. (SPGI) shares were up in last trading by 0.31% to $126.92. It experienced lighter than average volume on day. The stock increased in value by almost 0.86% over the past week and grew 12.9% in the past month. It is currently trading 9.7% above its 50 day moving average and 9.08% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.22% decrease in value from its one year high of $128.49. The RSI indicator value of 76.61, lead us to believe that it may reverse gains in the near term.

S&P Global Inc. provides independent ratings, benchmarks, analytics, and data to the capital and commodity markets worldwide. It operates through three segments: Ratings, Market and Commodities Intelligence, and S&P Dow Jones Indices. The Ratings segment provides credit ratings, research and analytics, information, and benchmarks to the investors, issuers, and other market participants. The Market and Commodities Intelligence segment offers multi-asset-class data; and research and analytical capabilities, which integrate cross-asset analytics and desktop services, and deliver access to information, data, analytic services, and pricing and quality benchmarks to its customers in the commodity and energy markets. The S&P Dow Jones Indices segment provides index that maintains various valuation and index benchmarks for investment advisors, wealth managers, and institutional investors. The company was formerly known as McGraw Hill Financial, Inc. and changed its name to S&P Global Inc. in April 2016. S&P Global Inc. was founded in 1888 and is headquartered in New York, New York.

 

Investor’s Alert: CVS Health Corporation (CVS), KeyCorp (KEY), Morgan Stanley (MS)

CVS Health Corporation (CVS) continued its upward trend with the stock climbing 1.58% or $1.22 to close the day at $78.53 on higher than average trading volume of 9.33M shares, compared to its three month average trading volume of 8.03M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by 3.0993% for last three months and its recent gains have pushed the stock slightly up 0.12% YTD, versus the health care plans industry which is up 2.46% for the same period. The RSI of 49.05 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2016, it had 23 retail specialty pharmacy stores, 13 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 84 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,709 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 38 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

KeyCorp (KEY) had a active trading with around 8.97M shares changing hands compared to its three month average trading volume of 14.06M. The stock traded between $18.12 and $18.32 before closing at the price of $18.26 with 0.66% change on the day. The Cleveland Ohio 44114 based company is currently trading 89.65% above its 52 week low of $10.21 and -2.72% below its 52 week high of $18.77. Both the RSI indicator and target price of 52.08 and $19.9 respectively, lead us to believe that it should be put on hold over the coming weeks.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The company’s Key Community Bank segment offers deposit and investment products; personal finance services and loans, including residential mortgages, home equity, credit cards, and various installment loans for individuals; deposits, investment and credit products, and business advisory services to small businesses; and financial, estate and retirement planning, and asset management services to high-net-worth clients. This segment also provides commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange services to mid-sized businesses. Its Key Corporate Bank segment offers a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans for middle market clients comprising consumer, energy, healthcare, industrial, public, real estate, and technology sectors. In addition, KeyCorp provides personal, securities lending, and custody services; access to mutual funds; treasury, investment banking, international banking, and investment management services; public retirement plans, and foundations and endowments plans; and financial services consisting of community development financing, securities underwriting, and brokerage, as well as merchant services. As of December 31, 2015, the company operated 966 retail banking branches and 1,257 automated teller machines in 12 states, as well as a telephone banking call center. KeyCorp was founded in 1849 and is headquartered in Cleveland, Ohio.

Morgan Stanley (MS) traded within a range of $44.34 to $45.15 after opening the day at $45.13. The company has seen its stock increase in value by 6.28% so far this year. The stock was down close to -0.33% on light volume in last trading session and closed at $44.7 per share. After the recent fall, the stock is currently holding -0.73% below its 52 week high of $45.15 and 116.13% above its 12-month low of $22.68. The shares are up by over 22.96% in the last three months, and the RSI indicator value of 58.13 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals worldwide. The company’s Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance. This segment also provides sales and trading services, such as sales, financing, and market-making services in equity securities and fixed income products, including foreign exchange and commodities, as well as prime brokerage services; and corporate lending services, credit products, and investments and research services. Its Wealth Management segment offers various financial services and solutions covering brokerage and investment advisory services, market-making services in fixed income securities, financial and wealth planning services, annuity and insurance products, credit and other lending products, and banking and retirement plan services to individual investors, small-to-medium sized businesses, and institutions. The company’s Investment Management segment provides various investment strategies and products comprising asset management, including equity, fixed income, liquidity, alternatives, and managed futures products. This segment is also involved in merchant banking and real estate investing businesses. Morgan Stanley was founded in 1924 and is headquartered in New York, New York.

 

Stocks Alert: Netflix, Inc. (NFLX), The Procter & Gamble Company (PG), CVS Health Corporation (CVS)

Netflix, Inc. (NFLX) grew with the stock adding 0.51% or $0.74 to close at $144.74 on light trading volume of 6.88M compared its three months average trading volume of 7.34M. The Los Gatos California 95032 based company operating under the CATV Systems industry has been trending up for the last 52 weeks, with the shares price now 68.05% up for the period and up by 16.91% so far this year. With price target of $147.18 and a 81.04% rebound from 52-week low, Netflix, Inc. has plenty of upside potential, making it a hold with a view buy.

Netflix, Inc., an Internet television network, engages in the Internet delivery of television (TV) shows and movies on various Internet-connected screens. The company operates in three segments: Domestic Streaming, International Streaming, and Domestic DVD. It offers members with the ability to receive streaming content through a host of Internet-connected screens, including TVs, digital video players, television set-top boxes, and mobile devices. The company also provides DVDs-by-mail membership services. It serves approximately 93 million streaming members in 190 countries. Netflix, Inc. was founded in 1997 and is headquartered in Los Gatos, California.

The Procter & Gamble Company (PG) gained $0.32 to close the day at a new closing price of $88.33, a 0.36% increase in value from its previous closing price that moved the stock 14.48% above its 52 week low of $79.1. A total of 6.81M shares exchanged hands during the day compared with its three month average trading volume of 9.14M. The stock, which fluctuated between $87.81 and $88.34 during the day, currently situated -0.68% below its 52 week high. The stock is up by 5.49% in the past one month and up by 2.85% over the past three months. With a one year target estimate of $90.53 and RSI of 68.64, the stock still has upside potential, making it a hold for now.

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, India, the Middle East, Africa, and Latin America. The company’s Beauty segment offers hair care products comprising conditioners, shampoos, styling aids, and treatments; and antiperspirants and deodorants, personal cleansing, and skin care products. This segment markets its products under the Head & Shoulders, Olay, Pantene, Rejoice, Old Spice, Safeguard, and SK-II brands. Its Grooming segment provides blades and razors, pre- and post-shave products, and other shave care products, as well as appliances under the Braun, Fusion, Gillette, Mach3, Prestobarba, and Venus brands. The company’s Health Care segment offers toothbrushes, toothpaste, and other oral care products; and gastrointestinal, rapid diagnostics, respiratory, vitamins/minerals/supplements, and other healthcare products under the Oral-B, Crest, Prilosec, Vicks, Metamucil, Pepto Bismol, and Align brands. Its Fabric & Home Care segment provides fabric care products, including fabric enhancers, laundry additives, and laundry detergents; and home care products comprising air care, dish care, P&G professional, and surface care products under the Tide, Ariel, Downy, Gain, Cascade, Dawn, Febreze, Mr. Clean, and Swiffer brands. The company’s Baby, Feminine & Family Care segment offers baby care products, such as baby wipes, diapers, and pants; adult incontinence and feminine care products; and family care products, such as paper towels, tissues, and toilet papers. This segment markets its products under the Pampers, Always, Bounty, Charmin, Luvs, and Tampax brands. The company sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, distributors, baby stores, specialty beauty stores, e-commerce, high-frequency stores, and pharmacies. The Procter & Gamble Company was founded in 1837 and is based in Cincinnati, Ohio.

CVS Health Corporation (CVS) shares were up in last trading by 0.88% to $77.03. It experienced lighter than average volume on day. The stock decreased in value by almost -1.21% over the past week and fell -5.15% in the past month. It is currently trading -2.5% below its 50 day moving average and -12.97% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -26.67% decrease in value from its one year high of $106.67. The RSI indicator value of 42.61, lead us to believe that it is a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Worth Watching Stocks: Visa Inc. (V), Marathon Oil Corporation (MRO), CVS Health Corporation (CVS)

Visa Inc. (V) saw its value decrease by -0.29% as the stock dropped $-0.25 to finish the day at a closing price of $85.83. The stock was lighter in trading and has fluctuated between $66.12-$86.82 per share for the past year. The shares, which traded within a range of $85.51 to $86.1 during the day, are up by 6.65% in the past three months and up by 7.51% over the past six months. It is currently trading 4.06% above its 20 day moving average and 7.1% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $95.48 a share over the next twelve months. The current relative strength index (RSI) reading is 71.94.The technical indicator do not lead us to believe the stock will see more gains any time soon.

Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank’s current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

Marathon Oil Corporation (MRO) shares were down in last trading by -4.12% to $16.52. It experienced lighter than average volume on day. The stock decreased in value by almost -0.06% over the past week and fell -9.13% in the past month. It is currently trading -6.25% below its 50 day moving average and 9.19% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -14.32% decrease in value from its one year high of $19.28. The RSI indicator value of 38.1, lead us to believe that it is a hold for now.

Marathon Oil Corporation operates as an energy company. It operates through three segments: North America E&P, International E&P, and Oil Sands Mining. The North America E&P segment develops, explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in North America. The International Exploration and Production segment explores for, produces, and markets crude oil and condensate, natural gas liquids, and natural gas in Equatorial Guinea, Gabon, the Kurdistan Region of Iraq, Libya, and the United Kingdom; and produces and markets products manufactured from natural gas, such as liquefied natural gas and methanol in Equatorial Guinea. The Oil Sands Mining segment mines, extracts, and transports bitumen from oil sands deposits in Alberta and Canada; and upgrades the bitumen to produce and market synthetic crude oil and vacuum gas oil. As of December 31, 2015, it had rights to participate in developed and undeveloped leases totaling approximately 32,000 net acres. The company was formerly known as USX Corporation and changed its name to Marathon Oil Corporation in July 2001. Marathon Oil Corporation was founded in 1887 and is headquartered in Houston, Texas.

CVS Health Corporation (CVS) traded within a range of $75.53 to $76.82 after opening the day at $75.6. The company has seen its stock decrease in value by -3.02% so far this year. The stock was up close to 0.81% on active volume in last trading session and closed at $76.07 per share. After the recent gain, the stock is currently holding -27.58% below its 52 week high of $106.67 and 10.43% above its 12-month low of $69.3. The shares are down by over -6.18% in the last three months, and the RSI indicator value of 37.12 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks in Review: Merck & Co., Inc. (MRK), CVS Health Corporation (CVS), Bristol-Myers Squibb Company (BMY)

Merck & Co., Inc. (MRK) traded within a range of $62.53 to $64.21 after opening the day at $62.64. The company has seen its stock increase in value by 9.02% so far this year. The stock was up close to 3.35% on active volume in last trading session and closed at $64.18 per share. After the recent gain, the stock is currently holding -1.2% below its 52 week high of $65.46 and 38.11% above its 12-month low of $47.97. The shares are up by over 9.06% in the last three months, and the RSI indicator value of 66.46 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Merck & Co., Inc. provides healthcare solutions worldwide. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, male pattern hair loss, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; non-sedating antihistamine; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; chewable tablets to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures to develop molecule compounds for various cancer treatments. The company was founded in 1891 and is headquartered in Kenilworth, New Jersey.

CVS Health Corporation (CVS) continued its downward trend with the stock declining -4.07% or $-3.17 to close the day at $74.8 on light trading volume of 18.76M shares, compared to its three month average trading volume of 8.66M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -20.03%, compared to the industry which has advanced 14.32% over the same period. With RSI of 31.42, the stock should still continue to rise and get closer to its one year target estimate of $87.95, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Bristol-Myers Squibb Company (BMY) gained $1.21 to close the day at a new closing price of $50.5, a 2.45% increase in value from its previous closing price that moved the stock 9.76% above its 52 week low of $46.01. A total of 18.59M shares exchanged hands during the day compared with its three month average trading volume of 12.23M. The stock, which fluctuated between $49.27 and $50.89 during the day, currently situated -33.63% below its 52 week high. The stock is down by -14.49% in the past one month and up by 0.07% over the past three months. With a one year target estimate of $59.06 and RSI of 40.35, the stock still has upside potential, making it a hold for now.

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. It offers chemically-synthesized drug or small molecule, and biologic in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; immunoscience; cardiovascular; and neuroscience. Its products include Baraclude for the treatment of chronic hepatitis B virus infection; Daklinza and Sunvepra for the treatment of hepatitis C virus infection; Reyataz and Sustiva for the treatment of HIV; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; Erbitux, an IgG1 monoclonal antibody that blocks the epidermal growth factor receptor; Opdivo, a fully human monoclonal antibody for non-small cell lung and renal cell cancer, and melanoma; Sprycel, a tyrosine kinase inhibitor for the treatment of adults with Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for metastatic melanoma; Abilify, an antipsychotic agent for adults with schizophrenia, bipolar mania disorder, and depressive disorder; Orencia to treat rheumatoid arthritis; and Eliquis, an oral factor Xa inhibitor targeted at stroke prevention in atrial fibrillation. Its products pipeline includes Beclabuvir, a non-nucleoside NS5B inhibitor for the treatment of HCV; BMS-663068, an investigational compound that is being studied in HIV-1; and Prostvac, a Phase III prostate-specific antigen to treat asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. The company has clinical trial collaborations with Calithera Biosciences, Inc. and Janssen Biotech, Inc.; and a research collaboration with GeneCentric Diagnostics, Inc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.

 

Stocks Under Review: MetLife, Inc. (MET), Archer-Daniels-Midland Company (ADM), CVS Health Corporation (CVS)

MetLife, Inc. (MET) continued its downward trend with the stock declining -0.89% or $-0.49 to close the day at $54.41 on light trading volume of 5.14M shares, compared to its three month average trading volume of 6.36M. The New York New York 10166 based company has been outperforming the life insurance group over the past 52 weeks, with the stock gaining 27.36%, compared to the industry which has advanced 28.8% over the same period. With RSI of 48.18, the stock should still continue to rise and get closer to its one year target estimate of $60.36, making it a hold for now.

MetLife, Inc. provides life insurance, annuities, employee benefits, and asset management products in the United States, Japan, Latin America, Asia, Europe, and the Middle East. It operates in six segments: Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America; Asia; and Europe, the Middle East and Africa. The company provides variable, universal, term, and whole life products; individual disability income products; personal lines property and casualty insurance, including private passenger automobile, homeowners, and personal excess liability insurance; and variable and fixed annuities for asset accumulation and distribution needs, as well as mutual funds and other securities products. It also offers group insurance products, such as variable, universal, and term life products; dental, group short- and long-term disability, and accidental death and dismemberment coverages; and voluntary and worksite products consisting of personal lines property and casualty insurance, as well as LTC, prepaid legal plans, and critical illness products. In addition, the company provides annuity and investment products comprising guaranteed interest products and other stable value products, income annuities, and separate account contracts for the investment management of defined benefit and defined contribution plan assets; and structured settlements and products to fund postretirement benefits and company-, bank- or trust-owned life insurance, as well as health insurance, group medical, credit insurance, endowment, retirement, and savings products. It serves individuals and corporations, as well as other institutions and their employees. The company sells its products through sales forces, third-party organizations, independent agents, and property and casualty specialists, as well as through career agency, bancassurance, direct marketing, brokerage, and e-commerce channels. MetLife, Inc. was founded in 1863 and is based in New York, New York.

Archer-Daniels-Midland Company (ADM) grew with the stock adding 0.29% or $0.13 to close at $44.26 on active trading volume of 5.04M compared its three months average trading volume of 3.49M. The Chicago Illinois 60601 based company operating under the Farm Products industry has been trending up for the last 52 weeks, with the shares price now 28.76% up for the period and down by -3.04% so far this year. With price target of $45.08 and a 44.56% rebound from 52-week low, Archer-Daniels-Midland Company has plenty of upside potential, making it a hold with a view buy.

Archer-Daniels-Midland Company procures, transports, stores, processes, and merchandises agricultural commodities and products. Its Agricultural Services segment offers agricultural commodities, such as oilseeds, corn, wheat, milo, oats, rice, and barley; and resells those commodities as food and feed ingredients, and raw materials for the agricultural processing industry. The segment is also involved in structured trade finance and the processing of wheat into wheat flour. Its Corn Processing segment offers ingredients used in the food and beverage industry, including sweeteners, starch, syrup, glucose, and dextrose; bio products; alcohol, amino acids, and other food and animal feed ingredients; and ethyl alcohol for industrial use as ethanol or as beverage grade. This segment also offers corn gluten feed and meal, and distillers’ grains; vegetable oil and protein meal; formula feeds, and animal health and nutrition products; and citric acids and glycols for food and industrial products, as well as operates a sugarcane ethanol plant. The company’s Oilseeds Processing segment processes soybeans and soft seeds into vegetable oils and protein meals. It offers ingredients for the food, feed, energy, and industrial products industries; crude vegetable and salad oils; partially refined oils; oilseed protein meals; peanuts, tree nuts, and peanut-derived ingredients; cottonseed flour for the pharmaceutical industry; cotton cellulose pulp for the chemical, paper, and filter markets; and agricultural commodity raw materials. Its Wild Flavors and Specialty Ingredients segment offers natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products, edible beans, and other specialty food and feed ingredients. The company is also involved in futures commission and insurance activities. Archer-Daniels-Midland Company was founded in 1898 and is headquartered in Chicago, Illinois.

CVS Health Corporation (CVS) continued its upward trend with the stock climbing 0.17% or $0.13 to close the day at $78.81 on lower than average trading volume of 6.42M shares, compared to its three month average trading volume of 8.67M. The Woonsocket Rhode Island 02895 based company has been outperforming the health care plans companies by -4.9998% for last three months and its recent losses have trimmed gains to 0.48% YTD, versus the health care plans industry which is up 1.69% for the same period. The RSI of 44.68 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Eye Catching Stocks: CVS Health Corporation (CVS), Kinder Morgan, Inc. (KMI), General Motors Company (GM)

CVS Health Corporation (CVS) continued its downward trend with the stock declining -1.99% or $-1.58 to close the day at $77.75 on light trading volume of 10.89M shares, compared to its three month average trading volume of 8.71M. The Woonsocket Rhode Island 02895 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -15.2%, compared to the industry which has advanced 16.65% over the same period. With RSI of 40.1, the stock should still continue to rise and get closer to its one year target estimate of $87.95, making it a hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Kinder Morgan, Inc. (KMI) fell -0.18% during last trading as the stock lost $-0.04 to finish the day at $22.38 with about 10.61M shares changing hands, compared to its three month average trading volume of 13.62M. The $49.96B market cap company, which fluctuated between $22.2 and $22.47 during the day, currently situated 72.02% above its 52 week low of $13.26 and -3.62% away from its one year high of $23.36. The RSI of 58.02 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Kinder Morgan, Inc. operates as an energy infrastructure company in North America. It operates through Natural Gas Pipelines, CO2, Terminals, Products Pipelines, Kinder Morgan Canada, and Other segments. The Natural Gas Pipelines segment owns and operates interstate and intrastate natural gas pipeline and storage systems; natural gas and crude oil gathering systems, and natural gas processing and treating facilities; natural gas liquids fractionation facilities and transportation systems; and liquefied natural gas facilities. The CO2 segment produces, transports, and markets CO2 for use in enhanced oil recovery projects; and owns interests in oil-producing fields, gas processing plants, and crude oil pipelines in the Permian Basin region of West Texas. The Terminals segment owns and operates liquids and bulk terminals that transload and store refined petroleum products, crude oil, and condensate, as well as bulk products, including coal, petroleum coke, cement, alumina, salt, and other bulk chemicals; and owns and operates tankers. The Products Pipelines segment owns and operates refined petroleum products, and crude oil and condensate pipelines; and associated product terminals and petroleum pipeline transmix facilities. The Kinder Morgan Canada segment owns and operates Trans Mountain pipeline system that transports crude oil and refined petroleum products from Edmonton, Alberta, and Canada to marketing terminals and refineries in British Columbia, Canada, and Washington; and jet fuel aviation turbine fuel pipeline that serves the Vancouver (Canada) International Airport. The Other segment includes various physical natural gas contracts with power plants. Kinder Morgan, Inc. owns interests in or operates approximately 84,000 miles of pipelines and 180 terminals. The company was formerly known as Kinder Morgan Holdco LLC and changed its name to Kinder Morgan, Inc. in February 2011. Kinder Morgan, Inc. was founded in 1936 and is headquartered in Houston, Texas.

General Motors Company (GM) saw its value decrease by -1.36% as the stock dropped $-0.51 to finish the day at a closing price of $37.01. The stock was lighter in trading and has fluctuated between $26.69-$38.38 per share for the past year. The shares, which traded within a range of $36.88 to $37.59 during the day, are up by 18.47% in the past three months and up by 22.17% over the past six months. It is currently trading 0.78% above its 20 day moving average and 3.65% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $38.45 a share over the next twelve months. The current relative strength index (RSI) reading is 53.81. The technical indicator lead us to believe there will be no major movement any time soon, hold.

General Motors Company designs, builds, and sells cars, crossovers, trucks, and automobile parts worldwide. The company operates through GM North America, GM Europe, GM International Operations, GM South America, and GM Financial segments. It markets its vehicles primarily under the Buick, Cadillac, Chevrolet, GMC, Opel, Holden, Vauxhall, Baojun, Jiefang, and Wuling brand names. The company also sells cars and trucks to dealers for consumer retail sales, as well as to fleet customers, including daily rental car companies, commercial fleet customers, leasing companies, and governments. In addition, it offers connected safety, security and mobility solutions, and information technology services. The company, through its subsidiary, General Motors Financial Company, Inc., provides automotive financing services. General Motors Company was founded in 1897 and is based in Detroit, Michigan.

 

Investor’s Alert: Coty Inc. (COTY), Host Hotels & Resorts, Inc. (HST), CVS Health Corporation (CVS)

Coty Inc. (COTY) continued its upward trend with the stock climbing 2.79% or $0.53 to close the day at $19.53 on lower than average trading volume of 10.81M shares, compared to its three month average trading volume of 7M. The New York New York 10118 based company has been outperforming the personal products companies by -13.6209% for last three months and its recent losses have trimmed gains to 6.66% YTD, versus the personal products industry which is up 4.78% for the same period. The RSI of 58.69 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Coty Inc., together with its subsidiaries, manufactures, markets, and distributes beauty products worldwide. The company operates through four segments: Fragrances, Color Cosmetics, Skin & Body Care, and Brazil Acquisition. It offers fragrances under the Calvin Klein, Marc Jacobs, Davidoff, Chloé, Balenciaga, Beyoncé, Bottega Veneta, Guess?, Katy Perry, Miu Miu, and Roberto Cavalli brand names. The company also provides lip, eye, nail, and facial color products under the Bourjois, Rimmel, Sally Hansen, and OPI brands. In addition, it offers shower gels, deodorants, skin care, and sun treatment products under the adidas, Lancaster, philosophy, and Playboy brand names; and hair straighteners, hair dryers, curlers, and hair brushes; and spray, serum, cream, and foam product lines to curl, fix, protect, shine, straighten, and volumize hair. The company also markets its products under the Astor, Coty, Joop!, Jovan, Manhattan, and N.Y.C. New York Color brands. It sells its products through retailers, including hypermarkets, supermarkets, independent and chain drug stores and pharmacies, upscale perfumeries, upscale and mid-tier department stores, nail salons, specialty retailers, duty-free shops and traditional food, and drug and mass retailers. Coty Inc. was founded in 1904 and is headquartered in New York, New York.

Host Hotels & Resorts, Inc. (HST) had a light trading with around 10.63M shares changing hands compared to its three month average trading volume of 10.76M. The stock traded between $18.21 and $18.49 before closing at the price of $18.48 with 1.15% change on the day. The Bethesda Maryland 20817 based company is currently trading 49.97% above its 52 week low of $12.98 and -5.13% below its 52 week high of $19.51. Both the RSI indicator and target price of 56.39 and $18.12 respectively, lead us to believe that it should be put on hold over the coming weeks.

Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm primarily engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States. It also invests in Canada, Mexico, Chile, the United Kingdom, Italy, Spain, and Poland. The firm primarily invests in luxury and upper upscale hotels. It was formerly known as Host Marriott Corporation. Host Hotels & Resorts, Inc. was founded in 1927 and is based in Bethesda, Maryland.

CVS Health Corporation (CVS) traded within a range of $79.42 to $82.2 after opening the day at $81.92. The company has seen its stock increase in value by 1.34% so far this year. The stock was down close to -2.8% on active volume in last trading session and closed at $79.49 per share. After the recent fall, the stock is currently holding -24.33% below its 52 week high of $106.67 and 15.4% above its 12-month low of $69.3. The shares are down by over -9.12% in the last three months, and the RSI indicator value of 47.48 is neither bullish nor bearish, tempting investors to stay on the sidelines.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

 

Stocks To Track: CVS Health Corporation (CVS), KB Home (KBH), FireEye, Inc. (FEYE)

CVS Health Corporation (CVS) climbed 0.65% during last trading as the stock added $0.53 to finish the day at $81.78 with about 4.71M shares changing hands, compared to its three month average trading volume of 8.52M. The $88.97B market cap company, which fluctuated between $81.12 and $82.15 during the day, currently situated 18.72% above its 52 week low of $69.3 and -22.15% away from its one year high of $106.67. The RSI of 59.54 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

KB Home (KBH) gained $0.47 to close the day at a new closing price of $16.75, a 2.89% increase in value from its previous closing price that moved the stock 80.26% above its 52 week low of $9.34. A total of 4.74M shares exchanged hands during the day compared with its three month average trading volume of 2.44M. The stock, which fluctuated between $16.16 and $16.85 during the day, currently situated -3.62% below its 52 week high. The stock is up by 1.03% in the past one month and up by 13.83% over the past three months. With a one year target estimate of $16.92 and RSI of 56.37, the stock still has upside potential, making it a hold for now.

KB Home operates as a homebuilding company in the United States. It constructs and sells various homes, including attached and detached single-family residential homes, townhomes, and condominiums primarily for first-time, move-up, and active adult homebuyers. The company also provides property and casualty insurance, as well as earthquake, flood, and personal property insurance to its homebuyers; title services; and mortgage banking services, including residential mortgage loan originations to its homebuyers. It has operations in California, Arizona, Nevada, Colorado, Florida, Maryland, North Carolina, and Texas. The company was formerly known as Kaufman and Broad Home Corporation and changed its name to KB Home in January 2001. KB Home was founded in 1957 and is headquartered in Los Angeles, California.

FireEye, Inc. (FEYE) had a active trading with around 4.71M shares changing hands compared to its three month average trading volume of 4.33M. The stock traded between $12.59 and $13.12 before closing at the price of $12.77 with -1.39% change on the day. The Milpitas California 95035 based company is currently trading 17.48% above its 52 week low of $10.87 and -34.95% below its 52 week high of $19.63. Both the RSI indicator and target price of 48.18 and $16.58 respectively, lead us to believe that it should be put on hold over the coming weeks.

FireEye, Inc. provides cybersecurity solutions for detecting, preventing, analyzing, and resolving cyber-attacks. The company offers vector-specific appliance solutions that provide threat protection from network to endpoint for inbound and outbound network traffic that may contain sensitive information. It also offers Central Management System that provides cross-enterprise threat data correlation to identify and block attacks across multiple attack vectors; and Threat Analytics Platform to identify and respond to cyber threats by correlating enterprise-generated security event data from any security product with real-time threat intelligence, as well as Malware Analysis System to manually execute and inspect advanced malware, zero-day, and other advanced cyber-attacks embedded in files, email attachments, and Web objects. In addition, the company offers Network Forensics Platform that helps in detecting threats and view specific packets and sessions before, during, and after the attack to confirm what may have triggered a malware download or callback; Investigation Analysis System, a centralized analytical interface to the Network Forensics Platform; and Mandiant Intelligent Response that enables remote investigation of endpoints and allows security teams to collect targeted forensic data to identify attacker behavior, tools, and techniques. Further, it provides cloud-based subscription services; Security-as-a-Service; and incident response, compromise assessments, and related consulting, as well as training and professional, and customer support and maintenance services. FireEye, Inc. provides its products and services through distributors, resellers, and strategic partners in the United States, the Asia Pacific, Japan, Europe, the Middle East, Africa, and others. The company was formerly known as NetForts, Inc. and changed its name to FireEye, Inc. in September 2005. FireEye, Inc. was founded in 2004 and is headquartered in Milpitas, California.